Advisory - Important safety information for people with diabetes using NovoPen Echo or NovoPen 5
OTTAWA, July 25, 2017 /CNW/ -
Issue Health Canada is advising Canadians that Novo Nordisk A/S has updated a voluntary recall of insulin cartridge holders used in certain lots of its NovoPen Echo and NovoPen 5 insulin pens. The company detected that the cartridge holders may crack or break if exposed to certain chemicals, such as some cleaning agents.
Affected Products NovoPen Echo:
Device Lot Number
Package Lot Number
DUG2373
DVG1368
EVG2915
EVG3010
EVG4252
EVG5699
EVG5946
EVG5963
FVG7337
FVG7561
FVG8131
FVG8132
FVG8212
FVG8414
FVG8994
FVG8997
DUG2373-5
DVG1368-B
EVG2915-7
EVG3010-2
EVG4252-6
EVG5699-6
EVG5946-7
EVG5963-1
FVG7337-2
FVG7561-1
FVG8131-5
FVG8132-6
FVG8212-1
FVG8414-9
FVG8994-1
FVG8997-1
NovoPen 5:
Device Lot Number
Package Lot Number
EVG5564
EVG3337
EVG5564
EVG0915
FVG7336
FVG7377
EVG6240 EVG6241 FVG6867 FVG6868 FVG7469 FVG7568
Background Novo Nordisk A/S has advised that using a device with a cracked or broken cartridge holder can result in a smaller dose of insulin than expected, which may lead to hyperglycemia (high blood sugar). According to Novo Nordisk A/S, the risk of experiencing high blood sugar with the use of a device with an affected cartridge holder is evaluated to be less than 0.1 per cent. This means that less than one in 1,000 patients with an affected cartridge holder will experience high blood sugar.
Warning symptoms of high blood sugar include: flushed, dry skin, sleepiness or tiredness, dry mouth, breath that smells fruity or like acetone (nail polish remover), frequent urination, feeling thirsty, loss of appetite, nausea, and vomiting. It is possible that high blood sugar may only be seen by measuring blood sugar levels, and may not display any physical signs.
Novo Nordisk A/S has confirmed that the cartridge holder issue does not affect NovoPen Echo or NovoPen 5 devices with a lot number that is not mentioned above.
What consumers should do
Do not stop treatment without consulting your health care professional.
Contact Novo Nordisk Customer Service in order to receive an unaffected cartridge holder for your NovoPen Echo or NovoPen 5 product, or if you have any questions about this recall. You can contact the company by calling 1-800-465-4434, emailing [email protected], or by completing the form on the company's website.
In the event that you experience symptoms of high blood sugar or any health concerns involving this product, contact your healthcare professional for advice. Measure your blood sugar levels as instructed by your healthcare professional, and more frequently if symptoms of high or low blood sugar develop unexpectedly.
Report complaints about health products to Health Canada by calling toll-free at 1-800-267-9675, or complete an online complaint form.
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.
Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.
Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...
The "Infectious Vaccine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.
Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...